Contineum Therapeutics, Inc. - CTNM

Ownership (Schedule 13D / 13G) · latest 50 filings · Back to all files
Visible: 0
Filed Form Reporting person Percent Shares SEC
Feb 17, 2026 SCHEDULE 13G JANUS HENDERSON GROUP PLC 7.9% 2,448,979 View
Feb 17, 2026 SCHEDULE 13G Balyasny Asset Management L.P. 7.6% 2,312,800 View
Feb 17, 2026 SCHEDULE 13G BAM GP LLC 7.6% 2,312,800 View
Feb 17, 2026 SCHEDULE 13G Balyasny Asset Management Holdings LP 7.6% 2,312,800 View
Feb 17, 2026 SCHEDULE 13G Dames GP LLC 7.6% 2,312,800 View
Feb 17, 2026 SCHEDULE 13G Dmitry Balyasny 7.6% 2,312,800 View
Feb 17, 2026 SCHEDULE 13G/A RA Capital Management, L.P. 7.2% 2,179,711 View
Feb 17, 2026 SCHEDULE 13G/A Peter Kolchinsky 7.2% 2,179,711 View
Feb 17, 2026 SCHEDULE 13G/A Rajeev Shah 7.2% 2,179,711 View
Feb 17, 2026 SCHEDULE 13G/A RA Capital Healthcare Fund, L.P. 7.2% 2,179,711 View
Jan 29, 2026 SCHEDULE 13G/A Franklin Resources, Inc. 6.2% 1,879,367 View
Jan 29, 2026 SCHEDULE 13G/A Charles B. Johnson 0.0% 0 View
Jan 29, 2026 SCHEDULE 13G/A Rupert H. Johnson, Jr. 0.0% 0 View
Jan 29, 2026 SCHEDULE 13G/A Franklin Advisers, Inc. 6.2% 1,879,367 View
Nov 04, 2025 SCHEDULE 13G/A Franklin Resources, Inc. 7.7% 1,655,548 View
Nov 04, 2025 SCHEDULE 13G/A Charles B. Johnson 0.0% 0 View
Nov 04, 2025 SCHEDULE 13G/A Rupert H. Johnson, Jr. 0.0% 0 View
Nov 04, 2025 SCHEDULE 13G/A Franklin Advisers, Inc. 7.7% 1,655,548 View
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G. Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F). Amendments (/A) can repeat the same holder over time, so rows should not be summed. Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.